We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Myriad Hits Competitors With Patent Suit, Keeping DNA Patent Debate Alive
Myriad Hits Competitors With Patent Suit, Keeping DNA Patent Debate Alive
July 11, 2013
Myriad Genetics has filed suit against Ambry Genetics and Gene by Gene, two of its competitors that began marketing less-expensive versions of its diagnostic breast cancer test the same day a unanimous Supreme Court ruled against patenting isolated human DNA.